Research / April 2026 · Non-finding
Why congressional trades don’t overlap with insider buys (and what we learned trying to test it)
The idea we wanted to test
There’s a plausible-sounding conviction-stacking hypothesis: when a company insider files a Form 4 buy and a member of Congress has also bought that ticker in the prior 90 days, the combined signal should outperform insider buys at tickers with no congressional activity. Two independent informed actors putting their own money on the same name. We pre-registered a 12-month backtest to check it. A two-week sample-size sanity check killed the premise before we got to forward returns.
The numbers that stopped the test
In an April 16–29, 2025 Form 4 window with a 90-day House congressional lookback, the raw counts were:
- 225 qualifying Form 4 P-buys (NYSE / Nasdaq, price ≥ $2)
- 105 unique Form 4 buy tickers
- 355 House congressional purchases from 278 PTR filings
- 158 unique congressional-buy tickers
- 1 ticker in the intersection — and its congressional buys fell outside the 90-day window
- 0 in-window overlap events, out of 225 insider buys
Linear projection to 12 months: around 0–20 overlap events total. Our pre-registered gate required ≥ 100 to power a headline comparison. Gate fired STOP. We didn’t run the full pull.
The two lists don’t touch
Top insider-buy tickers
- NONE24
- RCG9
- TPL9
- NEOG8
- YORW6
- TEAF6
- DOC6
- ENX4
- IIF4
- AUBN4
Top congressional-buy tickers
- AMZN27
- ABBV12
- AMD12
- AAL10
- GOOG7
- ADBE7
- AAPL7
- ABT7
- MMM7
- IBM6
Buys in the 2-week window. No ticker appears in both columns.
Why they diverge
Form 4 P-transactions are mostly insiders buying their own employer. That universe is dominated by small- and mid-cap issuers and special situations — regional banks, biotechs, closed-end funds, recent IPOs, REITs. A CFO at a $400M regional bank doesn’t show up on anyone’s congressional trade radar.
Members of Congress trade through diversified brokerage accounts, often managed by advisors. Their disclosed purchases cluster in mega-caps and sector themes: big tech, big pharma, airlines, industrials. Those are companies where insiders rarely show up in the P-transaction stream — open-market CEO purchases at Apple or Amazon are unusual events, not weekly occurrences. The two pools barely touch.
What this means
Not adding to the scoring model. There’s no signal to extract here — not a weak one waiting for more data, not a statistically-invisible-but-economically-real edge. The mechanics of who files Form 4s and who trades through a Congressional brokerage account mean the candidate pool for the combined signal is essentially empty.
Next up: Test 3, repeat-buyer reliability — when the same insider buys the same ticker multiple times within a short window, does the signal strengthen with each repeat? That’s a hypothesis where the base rate is clearly large enough to test.
Known limits of this check
- House-only, no Senate. Senate PTR scraping was out of scope; at this base rate, adding Senate wouldn’t close the gap (senators trade the same mega-cap universe as House members).
- 45-day disclosure lag. Congressional PTRs can lag the transaction by up to 45 days. Our retrospective overlap view is more forgiving than real-time — and still produced zero overlaps.
- Window was 2 weeks. The projection from 2 weeks to 12 months is noisy, but the structural argument (disjoint ticker universes) doesn’t soften with more data.
research/data/congressional-overlap-nonfinding-2026-04/ in the repo. Source code for the pipeline is
at scripts/research/congressional-overlay-test/.